E-pharmacies, backed by the likes of LightRock, Temasek Holdings, TPG Growth, Naspers, Everstone, Fidelity Investments, Think Investments, CDPQ, Orios Ventures, Eight Roads and Fundamentum, have written to the Centre about their concerns over the sudden change in policy.